Clare Barnett
ORCID: 0000-0001-9236-1396
· 2 papers in corpus
Background: Several promising new medications containing low-dose estradiol (E2) in combination with a progestin and an additional component, such as gonadotropin-releasing hormone antagonists, are currently being developed for use in pre-m…